Immunodeficiencies Flashcards

1
Q

PIDs?

A

Primary inherited immunodeficiency - inheritance of mutation in either innate or adaptive immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Severity of mutation?

A

More than 300 defects associated so far, causing rare monogenic conditions
Severity depends on complete or partial LOF,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Paradoxical overactive immune response?

A

Caused by some IDs through regulation defects:

Autoinflammatory disorders 
Autoimmune disorders (Foxp3, AIRE, Fas gene defects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical phenotypes of PID?

A

Increased susceptibility to infection, especially opportunistic ones that would not normally cause disease

Mutations may affect:
immune cell development
activation
effector mechanisms

Mostly affect adaptive humoral response of B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Defects in innate immunity?

A

Phagocyte production, adhesion, activation and killing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LAD defects?

A

LAD1 - CD18 subunit, normally pairs with CD11a to form LFA1 for leukocyte extravasation
ALSO CD11b and CD11c for complement receptors CR3 and 4
= compromised neutrophil recruitment and phagocytosis
Bacterial and fungal severe infections early on

LAD2 - needed to synthesis sialyl-Lewis C ligand on neutrophils for rolling phase of leukocyte extravasation, with same effect as above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PRR sensing defects?

A

ALL TLRs except TLR3 need MYD88 and IRAK4 to recognise MAMPs
(IRAK4 also on IL1 and 18 receptors)
Defects in either = recurrent pyogenic bacterial infections with little inflammation

Affects leukocyte activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phagocyte killing defects?

A

NADPH oxidase enzyme complex in the phagolysosome generates ROS to kill microbes in neutrophils
Defects in this, fusing, or phagolysosome formation = no phagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chronic granulomatous disease?

A

Defects in NADPH complex for phagocytosis
= T cell mediated chronic inflammation and granuloma formation
Severity varies e.g. one X-linked variant still expresses some protein, treated with IFNy

Recurrent intracellular fungi and bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Defects in adaptive immunity?

A

Genes at almost every stage of lymphocyte development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Combined immunodeficiencies?

A

T helpers needed for complete B cell activation, so T cell deficiencies also affect the humoral response
T cells and NK cells also overlap in development, so NK cells also affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SCIDs?

A

Severe combined immunodeficiencies - complete failure of T cell development, through:

  1. Defective cytokine signalling in T cell precursors
  2. Defective V(D)J rearrangement in developing lymphocytes
  3. Premature death of the lymphoid lineage as toxic metabolites accumulate

Lead to direct/indirect B cell deficiency, or NK cell development failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Defective cytokine signalling SCIDs?

A

X-linked SCID, most commonly due to mutation in common y chain shared in IL2 cytokines (2,4,7,9,15 and 21)
(IL15 - NK cell development, IL7 - T cell)
B cells not affected - T-B+NK- SCID

Disproportionately affects males as X-linked

JAK-3 SCID (same as above but caused by autosomal recessive mutation)

IL7R SCID - only T cells through deletion of alpha chain = T-B+NK+ SCID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Defective V(D)J rearrangement in SCIDs?

A

In developing lymphocytes

RAG SCID - mutation of RAG1/2 = no formation of V exons, stopping B and T development = T-B-NK+ SCID

Artemis SCID - artermis gene mutation = impaired DNA repair of dsDNA cuts from RAG1/2 =T-B-NK+ SCID and increased radiation sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Premature death of lymphoid lineage in SCIDs?

A

ADA SCID - adenosine deaminase (ADA) enzyme defect impairs purine synthesis salvage pathway causing progressive defect in lymphocytes = profound lymphopenia = T-B-NK- SCID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

B cell effects causing PID?

A

Specific B cell targeting or absence of Th = indirectly
Most common form, occurs about 7-9months old when maternal antibodies decline
Recurrent bacterial infections
(fungal/viral fine as T cells intact)

17
Q

Absence of mature B cells disease?

A

X linked agammaglobulineia (XLA)
Pre-B cell stage, mutations in Burton’s tyrosine kinase for downstream signalling of preB cell receptors
Don’t pass pre-BCR quality control = profound deficiency

18
Q

Mature B cells with impaired function?

A

Most common form of PIDs
Generation of one or more Ig isotypes compromised
Mild recurrent infections in childhood

19
Q

Deficient T/B and T/APC communication?

A

Leads to hyper IgM syndromes
X-linked form-mutation in CD40 ligand gene, so failure of T cells to interact with receptor on B cells and APCs
No isotype switching = impaired macrophage and DC activation
Type 1 immunity impaired as less IL12

20
Q

Treating PIDs

A

Early intervention with antibiotics and antifungals
Replace missing component:
Protein replacement
Cell replacement with bone marrow/haemopoietic stem cell transplants
MORE SAFE:
Gene replacement
CRISP/Cas

21
Q

Secondary acquired immunodeficiency?

A

HIV/AIDS - therapeutic immune suppression/infection

Through defects acquired through life e.g. from malnutrition

22
Q

Clinical course of HIV infection?

A

2-6 weeks
Flu-like disease, spike and then dip in viral load as initial infection controlled
Then on: seroconversion, asymptomatic phase while CD4 T cells deplete and viral RNA increases
About 10 years later: symptomatic phase
Then AIDS = death

23
Q

Structure of HIV?

A

Retrovirus
Has reverse transcriptase for dsDNA integration to host DNA
Host-derived outermembrane to avoid immune recognition
Gp120 and gp41 = spike proteins (very few) for cell entry

24
Q

Cell tropism of HIV?

A

Infects CD4+ cells - T cells, monocytes/macrophages. DCs
Gp120 undergos conformational change for binding site for co-receptors:

CCR5-tropic = binds activated effector/memory T cells, immature DCs, monocytes/macrophages

CXCR4-tropic
Bind naive T cells, mature DCs

25
Transmission of HIV?
Bodily fluid, usually mucosal surfaces of genital and GI tract Local propagation in small amount of cells at entry site occurs, then transferred to draining LNs: Kills CD4+ memory T cells, peak viral load in plasma Also produces latent reservoirs for a self-sustaining infection in follicular DCs, lymph nodes
26
Founder virus?
Responsible for initial small infection, takes about a week to reach high enough numbers for lymph node drainage R5-tropic
27
Role of DCs in infection?
Transfers virus from periphery to notes by binding surface lectin molecules Retains virus on follicular DCs as source of virus throughout course
28
Replication cycle?
Attachment with gp120 to CD4 Fusion - gp41 Viral proteins enter cell, reverse transcriptase acts in error-prone way to avoid immune recognition Provirus active or latent in cell Activation - binds host machinery, move to surface and releases new HIV proteins in host-derived membrane Transfer also through cell:cell interaction at viral synapse
29
Why can't the immune system clear HIV?
High replication and mutation rate Latent reservoir = hide for long periods Camouflage
30
Anteretroviral drugs?
``` Viral protease inhibitors Reverse transcriptase inhibitors Integrase inhibitor Fusion inhibitors Co-receptor binding inhibitors ``` Drug combos needed to cope with rapid mutation rates - HAART
31
Drawbacks of drug treatments?
``` Cost Availability Only works on replicating virus Compliance - taken for life Side-effects; becomes chronic inflammatory condition ```
32
Sterilising cure?
Complete removal, very rare (London and Berlin patients) | HIV+ with leukaemia - got transplant with mutation in CCR5 gene, blocking HIV entry to cells
33
Issues with sterilising cure?
Transplantation risk Rarity of donors with CCR5delat32/delta32 mutation Second attempts caused switch in tropism to X4 so did not help
34
Problem with latency?
Key challenge to overcome, as drugs do not act on these viral molecules Early intervention needed to stop formation of the reservoir
35
Functional cure?
Aims to reduce viral load to that which the immune system can cope with, so drugs do not have to be taken for like
36
Current cure efforts?
Eliminate latency - shock/kick and kill Activate latent cells so hidden virus is exposed to treatment Lock down reservoir - inhibit HIV protein Tat to suppress activation if latent infected cells (functional cure) Make cells resistant to infection - gene therapy to remove CCR5, cut out integrated virus (sterilising) Develop antibody and cel-mediated vaccines e.g. broadly neutralising antibodies